Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

REGENERON PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: 9148477000

CIK: 0000872589
EIN: 133444607
State Location: NY
State of Inc.: NY

Nasdaq:REGN

Form: SCHEDULE 13G

Filing Date: 30 Apr 2026
Report Date:
Accepted: 30 Apr 2026 11:03 a.m.
Accession Number: 0002100119-26-001017

Act: 34
File Number: 005-41938
Film Number: 26922552

Documents

Primary Document

Accepted: 30 Apr 2026 11:03 a.m.

0002100119-26-001017-index-headers.html

Last Modified: 30 Apr 2026 11:03 a.m.

0002100119-26-001017-index.html

Last Modified: 30 Apr 2026 11:03 a.m.

0002100119-26-001017.txt

Last Modified: 30 Apr 2026 11:03 a.m.

primary_doc.xml

Last Modified: 30 Apr 2026 11:03 a.m.